Vitamin D: Metabolism

被引：74

作者：

Christakos, Sylvia ^{[1
]}

Ajibade, Dare V. ^{[1
]}

Dhawan, Puneet ^{[1
]}

Fechner, Adam J. ^{[2
]}

Mady, Leila J. ^{[1
]}

机构：

[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA

[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet & Gynecol & Womens Hlth, Newark, NJ 07103 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2012年 / 38卷 / 01期

关键词：

Vitamin D metabolites; Vitamin D hydroxylases; Vitamin D binding protein; FGF23; Kidney; Placenta; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE GENE; D-3 1-ALPHA-HYDROXYLASE GENE; DOMINANT HYPOPHOSPHATEMIC RICKETS; CHRONIC KIDNEY-DISEASE; D-DEFICIENCY RICKETS; D-BINDING PROTEIN; PARATHYROID-HORMONE; 1,25-DIHYDROXYVITAMIN D-3; PHYSIOLOGICAL-ROLE; D-RECEPTOR;

D O I：

10.1016/j.rdc.2012.03.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The biologically active metabolite of vitamin D, 1,25(OH)(2)D-3, affects mineral homeostasis and has numerous other diverse physiologic functions including effects on growth of cancer cells and protection against certain immune disorders. This article reviews the role of vitamin D hydroxylases in providing a tightly regulated supply of 1,25(OH)(2)D-3. The role of extrarenal 1 alpha(OH)ase in placenta and macrophages is also discussed, as well as regulation of vitamin D hydroxylases in aging and chronic kidney disease. Understanding specific factors involved in regulating the hydroxylases may lead to the design of drugs that can selectively modulate the hydroxylases. The ability to alter levels of these enzymes would have therapeutic potential for the treatment of various diseases, including bone loss disorders and certain immune diseases.

引用

页码：1 / +

页数：12

共 73 条

[1]

Ajibade DV, 2009, J BONE MINER RES S1, V24

[2] EFFECT OF AGE ON THE CONVERSION OF 25-HYDROXYVITAMIN-D3 TO 1,25-DIHYDROXYVITAMIN-D3 BY KIDNEY OF RAT [J].

ARMBRECHT, HJ ;

ZENSER, TV ;

DAVIS, BB .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :1118-1123

[3] Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders [J].

Bai, XY ;

Miao, DS ;

Li, JR ;

Goltzman, D ;

Karaplis, AC .

ENDOCRINOLOGY, 2004, 145 (11) :5269-5279

[4] DOES ESTRADIOL STIMULATE INVIVO PRODUCTION OF 1,25-DIHYDROXYVITAMIN D-3 IN RAT [J].

BAKSI, SN ;

KENNY, AD .

LIFE SCIENCES, 1978, 22 (09) :787-791

[5] SERUM-PROTEIN BINDING OF 1,25-DIHYDROXYVITAMIN-D - A REEVALUATION BY DIRECT MEASUREMENT OF FREE METABOLITE LEVELS [J].

BIKLE, DD ;

SIITERI, PK ;

RYZEN, E ;

HADDAD, JG ;

GEE, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (05) :969-975

[6] REGULATION BY CALCIUM OF IN-VIVO SYNTHESIS OF 1,25-DIHYDROXYCHOLECALCIFEROL AND 21,25-DIHYDROXYCHOLECALCIFEROL [J].

BOYLE, IT ;

GRAY, RW ;

DELUCA, HF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (09) :2131-&

[7] Regulation of 25-hydroxyvitamin D3 1α-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3 [J].

Brenza, HL ;

DeLuca, HF .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 381 (01) :143-152

[8] Parathyroid hormone activation of the 25-hydroxyvitamin D3-1α-hydroxylase gene promoter [J].

Brenza, HL ;

Kimmel-Jehan, C ;

Jehan, F ;

Shinki, T ;

Wakino, S ;

Anazawa, H ;

Suda, T ;

DeLuca, HF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1387-1391

[9]

CAPLAN RH, 1990, OBSTET GYNECOL, V76, P485

[10] Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase [J].

Cheng, JB ;

Levine, MA ;

Bell, NH ;

Mangelsdorf, DJ ;

Russell, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7711-7715

← 1 2 3 4 5 6 7 8 →